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Objective: There is a worldwide surge in numbers of elderly people requiring hemodialysis accompanying the prevailing
increase in longevity. There is a trend for central venous catheters to be preferentially placed in elderly patients, whereas
others recommend routine use of grafts for surgical access. In our center, age has not been a consideration in deciding to
construct arteriovenous access for hemodialysis. We reviewed our experience with arteriovenous access surgery in all
hemodialysis patients aged 80 years and older to determine if this approach is justiﬁed in terms of patency and life
expectancy.
Methods: A retrospective study was made of all patients aged 80 years and older who had surgery from January 2005 to
December 2009 at our national vascular access referral center. All patients had preoperative mapping and had ﬁstula
construction if the vein size was at least 3 mm. Otherwise they had brachiobasilic or brachioaxillary grafts. All patients
had routine access surveillance by Doppler ultrasound (duplex) and physical examination at regular intervals, and in-
terventions were carried out according to the ﬁndings. Type of access, success rate, maturation, primary and secondary
patency, and patient survival in the age group older than 80 years were noted.
Results: During the study period, 134 patients had 146 new accesses. There were 128 autogenous accesses (30 forearm,
91 upper arm, and seven transposed basilic veins) and 18 prosthetic accesses. Overall primary patency was 39%, 33%, and
23% at 12, 24, and 36 months. Secondary patency was 92%, 83%, and 77% at 12, 24, and 36 months. There was no
signiﬁcant difference in patency between the different types of accesses and between diabetic and nondiabetic patients.
Eleven upper arm and four forearm ﬁstulas had delayed maturation or nonmaturation. The relative risk for delayed
maturation or nonmaturation of forearm ﬁstulas (13.3%) compared with brachial-cephalic ﬁstula (12.1%) was 1.1030
(95% conﬁdence interval, 0.3973-3.204; P [ .8571). Median patient survival was 38 months, with 49 dying during
follow-up.
Conclusions: Contrary to recent recommendations favoring grafts for hemodialysis in patients older than 80 years, most
elderly patients in this study were found to have vasculature that was suitable for autogenous access construction, with
patency rates similar to those of their younger counterparts when adequate preoperative planning and postoperative
maintenance were carried out. Age alone should not disqualify patients older than 80 years from access surgery for he-
modialysis, nor should age disqualify these patients from the Fistula First Initiative. (J Vasc Surg 2015;61:177-83.)Renal replacement therapy has special implications for
older patients, who constitute the fastest growing sector
of the incident end-stage renal disease population.1 The
increased life expectancy of patients with chronic illnesses
has resulted in a considerable increase in the number of
older patients requiring dialysis. Improvements in dialysis
care have also contributed to the increasing numbers of
older dialysis patients.
Increasing age is related to lower maturation rates,
poorer ﬁstula patency, and lower life expectancy of the he-
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veins because of prior medical interventions and to have
atheroma or medial calciﬁcation affecting their radial or
brachial arteries.2 Such patients are more susceptible to
symptomatic steal syndrome because of inﬂow stenosis.
Because of the presence of multiple comorbidities in these
elderly patients, any disturbance of this delicate equilibrium
is likely to lead to serious complications. For these reasons,
many octogenarian patients have hemodialysis access
through a tunneled cuffed catheter.3 However, one study
has shown that patients older than 75 years with autoge-
nous vascular access can have patency that is similar to
that of younger patients.4
Notwithstanding current recommendations, there has
been a recent trend away from the Fistula First Initiative
in the age group older than 80 years,5 with age being
one of the four predictive factors used by Lok et al to pre-
dict failure to mature in ﬁstulas.6 In our center, the pa-
tient’s age has not been a consideration in the decision to
construct arteriovenous hemodialysis access, with the old-
est patient to have access surgery aged 94 years. We studied
patients older than 80 years who had hemodialysis access
construction in our center to determine the type of access
that was constructed, the success rate of the operations, the
maturation rates and the patency of the accesses, and the
mortality rates in these older patients.177
Table I. Demographic data for 134 patients having 146
new hemodialysis access operations during the study
period (January 1, 2005, to December 31, 2009)
Demographic No. (%)
Total patient No. 134 (100)
Gender
Male 88 (66)
Female 46 (34)
Hypertension 98 (73)
Ischemic heart disease 60 (45)
Congestive heart failure 32 (24)
Diabetes mellitus 53 (40)
Cerebrovascular accident 6 (4)
Peripheral vascular disease 11 (8)
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Study design. This was a retrospective study of pa-
tients in our hemodialysis access registry that is maintained
separately from hospital records and includes all patients
undergoing hemodialysis access construction, including
any subsequent follow-up and intervention. The study
was approved by the Ethics Committee of the Shaare
Zedek Medical Center and exempted from obtaining pa-
tient consent.
Study population. The Vascular Access Center at
Shaare Zedek Medical Center is a referral center for
vascular access surgery receiving patients for construction
and maintenance of arteriovenous accesses from all over
Israel. In the year 2012, 442 access operations were per-
formed, of which 357 were for new access construction
and 65 were surgical revisions of existing accesses. The
study included all patients older than 80 years with end-
stage renal disease who underwent hemodialysis access
construction from January 2005 to December 2009, when
follow-up also stopped.
Preoperative planning and surgery. All patients had
preoperative examinations clinically and with color-coded
Doppler ultrasound imaging to plan construction of the
access in the outpatient clinic by the surgeon performing the
operation.7,8 All preoperative and follow-up Doppler ultra-
sound examinations were performed by one of the two
dedicated access surgeons (D.S., I.G.). Forearm veins were
examined with a 5-cm blood pressure cuff inﬂated to 60 mm
Hg for at least 3 minutes and after exercising the hand and
gently tapping the veins. Forearm autogenous accesses were
constructed only if the veins dilated to a minimum of 3 mm
on Doppler ultrasound and radial artery diameter was
1.5 mm or more. If these criteria were not met, the access
was constructed above the elbow, again in veins that were a
minimum of 3 mm in diameter. Basilic vein transposition
was preferred to prosthetic access if the basilic vein diameter
was at least 4 mm. Prosthetic accesses with tapered 4- to
7-mm stretch expanded polytetraﬂuoroethylene (Gore-Tex;
W. L. Gore and Associates, Flagstaff, Ariz) were constructed
only in patients without suitable veins above the elbow
(calciﬁed arteries were deemed acceptable as long as the
pulse was palpable). In addition to the suitability of the
vessels for access construction, the draining veins and feeding
arteries were examined for stenosis of >50% in veins and
arteries or arterial peak systolic velocity (PSV) ratio of >3 for
the narrowed segment. If these were present or suspected on
Doppler ultrasound and there were no suitable vessels on the
contralateral side, patients were referred for preoperative
angioplasty or had endovascular treatment during the access
surgery. All anastomotic conﬁgurations were end to side.
The operations were performed by the same access surgeons
under regional anesthetic block, with full heparinization and
prophylactic antibiotics in grafts and transpositions, as
ambulatory procedures without hospitalization.
Postoperative follow-up. All patients entered our
routine access surveillance and maintenance program.7,8
Sutures were removed on postoperative days 10 to 14,and patients with grafts were referred to hemodialysis. All
patients were examined by Doppler ultrasound 1 month
after surgery and then every 3 months, when a complete
evaluation was carried out of the inﬂow arteries supplying
the ﬁstula, anastomoses, and outﬂow of the draining veins.
Criteria for endovascular interventions during
follow-up. The following criteria were used as indications for
angiographic assessment and possible intervention in autoge-
nous accesses: delayedmaturation (vein diameter<5mm and
ﬂow<500mL/min at 6weeks);Doppler ultrasound ﬁndings
of hemodynamically signiﬁcant stenosis; and clinical signs of
failing access, such as high venous pressure, difﬁculties in
achieving hemostasis after withdrawal of needles, and nonef-
ﬁcient renal replacement therapy.
In grafts, Doppler ultrasound criteria for angiography
were PSV at the venous anastomosis >6.0 m/s or ratio
of venous anastomosis PSV to midgraft PSV >3:1 or
measured ﬂow <600 mL/min. Stenosis >50% was consid-
ered hemodynamically signiﬁcant.
Patency and survival. Primary patency was the interval
from the time of access placement until any intervention
designed to maintain or to re-establish patency, access
thrombosis, or the time of measurement of patency. Sec-
ondary patency was the interval from the time of access
placement until access abandonment, thrombosis, or the
time of patency measurement including intervening manip-
ulations (surgical or endovascular interventions) designed to
re-establish functionality in thrombosed accesses.9 Secondary
patency was considered the most important end point
because it reﬂects the total time that the access is in use.
Statistical analysis. Findings were recorded in a
spreadsheet (Microsoft Ofﬁce Excel 2003; Microsoft Cor-
poration, Redmond, Wash). Statistical analysis was carried
out with Excel and Prism statistical software (Prism v 3.0;
GraphPad Software Inc, San Diego, Calif). Kaplan-Meier
survival curves were used to estimate access survival.
RESULTS
In our center from January 2005 to December 2009,
134 patients 80 years of age and older had 146 new arterio-
venous accesses constructed (Table I). Twelve patients had
Table II. Type of hemodialysis access surgery for 134
patients having 146 new hemodialysis access operations
during the study period (January 1, 2005, to December
31, 2009)
Type of access
Number of accesses
(% of subgroup)
% of
total
Native AVF (128 accesses [88%])
RA-CV 30 (23) 21
BrA-CV 91 (71) 62
BrA-TBasV/CV 7 (5) 5
PTFE graft (18 accesses [12%])
BrA-BasV (forearm) 16 (89) 11
BrA-AxV (arm) 2 (11) 1
Total accesses 146 (100) 100
AVF, Arteriovenous ﬁstula; BrA-AxV, brachial artery to axillary vein; BrA-
BasV, brachial artery to basilic vein; BrA-CV, brachial artery to cephalic vein;
BrA-TBasV/CV, brachial artery to transposed basilic or cephalic vein; PTFE,
polytetraﬂuoroethylene; RA-CV, radial artery to cephalic vein. Fig 1. Kaplan-Meier analysis of the primary patency (P patency)
and secondary patency (S patency) of arteriovenous accesses (ﬁs-
tulas and grafts) in hemodialysis patients older than 80 years. SEM,
Standard error of the mean.
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(median, 85 years; range, 80-95 years). Seventy-four patients
were aged 80 to 84 years, 52 patients were 85 to 89 years
old, and eight patients were 90 years or older. There were
only 46 women (35%), and 53 patients (40%) had diabetes
mellitus. Most patients had at least one comorbidity.
There were 128 new autogenous accesses constructed
(Table II). There were 30 (23%) forearm and 91 (71%) up-
per arm accesses. Seven (5%) of the upper arm autogenous
accesses were brachial artery to transposed basilic vein.
Only 18 patients (12%) had prosthetic accesses, 16 loop
forearm brachial-basilic and two upper arm brachial-
axillary accesses. Twenty-six patients had preoperative
venography. Four patients had intraoperative angioplasties
because of severe venous stenosis. Two patients had post-
operative bleeding that required surgical evacuation of he-
matomas, and none had infection in the immediate
postoperative period. Median follow-up was 13.3 months
(mean, 17.6 6 14.1 months; range, 0.4-56.3 months).
For all 146 accesses, primary patency at 12, 24, and
36 months was 39%, 33%, and 23%, respectively. Secondary
patency was 92%, 83%, and 77% (Fig 1). There were 198
therapeutic endovascular interventions in 76 of the accesses
during the study period, with an average of 0.9 interventions
per patient-year. Steal developed in 11 patients, nine with
brachial-cephalic ﬁstulas and one each with radial-cephalic
and brachial to transposed basilic vein ﬁstula. Four patients
with grade II-IV symptoms were referred for surgical revi-
sion because of the steal, three with brachial-cephalic ﬁstula
and the patient with basilic vein transposition. All four had
successful ﬂow reduction surgery by banding.
There were 18 prosthetic accesses, with only nine
remaining in follow-up at 12 months, so no meaningful
comparisons can be made.
There was no statistical difference between autogenous
forearm radial-cephalic access and upper arm brachial-
cephalic access patency (Fig 2). Thirty radial-cephalic forearm
autogenous accesses had a primary patency rate of 36% and32% and secondary patency of 93% and 84% at 12 and
24 months, respectively. The 91 autogenous upper arm
brachial-cephalic accesses had a 12-, 24-, and 36-month pri-
mary patency of 40%, 36%, and 29% and secondary patency
of 92%, 88%, and 79%, respectively. In patients who had
brachial-cephalic ﬁstulas, 40 of 91 accesses (44%) had 128 in-
terventions; and in patients with radial-cephalic ﬁstulas, 17 of
30 accesses (57%) had 28 interventions (P ¼ .2013).
Primary patency and secondary patency were similar for
accesses in diabetic compared with nondiabetic patients
(Fig 3).
Fifteen patients with ﬁstula had delayed maturation or
nonmaturation. Of these, there were 11 upper arm ﬁstulas:
nine underwent balloon-assisted maturation, of which seven
matured and went on to dialysis with use of the access, and
two failed to mature despite the intervention; one died
before having any intervention; and one was unsuitable for
intervention and received a new access. Four forearm ﬁstulas
failed to mature: two had balloon-assisted maturation, but
the accesses did not mature; one patient had early failure
of a forearm ﬁstula; and one matured after an additional
time interval. The relative risk for delayed maturation or
nonmaturation of forearm ﬁstulas (13.3%) compared with
brachial-cephalic ﬁstula (12.1%) was 1.1030 (95% conﬁ-
dence interval, 0.3973-3.204; P ¼ .8571).
Occlusions. Thirteen autogenous accesses were aban-
doned during the study period. Two were radial-cephalic,
nine were brachial-cephalic, one was brachial-axillary, and
one was a brachial to transposed basilic vein access. Two
patients refused new access construction and continued
hemodialysis through central catheters; one patient died
before a central catheter could be inserted. The others had
successful construction of a new access, seven autogenous
accesses and three grafts. One graft in the study occluded at
1.7 months, and this patient received an autogenous ﬁstula
in his dominant arm.
Fig 2. Kaplan-Meier analysis of the (a) primary patency and (b)
secondary patency of brachial-cephalic ﬁstulas vs radial-cephalic
ﬁstulas. AVF, Arteriovenous ﬁstula; BrA-CV, brachial artery to
cephalic vein; RA-CV, radial artery to cephalic vein; SEM, standard
error of the mean.
Fig 3. Kaplan-Meier analysis of the (a) primary patency and (b)
secondary patency of accesses in patients with diabetes mellitus
(DM) vs nondiabetic patients. SEM, Standard error of the mean.
JOURNAL OF VASCULAR SURGERY
180 Olsha et al January 2015Patient survival. Kaplan-Meier analysis showed a me-
dian patient survival of 38 months after access construction.
Forty-nine patients died during the study period. Median
survival of those patients who died was 10.7 months (mean,
15.6 6 13.1 months).
DISCUSSION
In this study, most patients aged 80 years and older
were found to have vasculature that was suitable for autog-
enous access construction, with only 12% prosthetic ac-
cesses. There were no signiﬁcant differences in patency
between forearm and upper arm autogenous accesses or
between patients with and without diabetes mellitus. Sec-
ondary patency was high in autogenous accesses, relying
on surveillance and interventions for maintenance of
patency.In the United States, there has been a steady rise in the
number of adult dialysis patients with end-stage renal fail-
ure. Since 2000, the prevalence among those aged 75 years
and older has grown 44%, whereas the growth in preva-
lence of those aged 20 to 44 years and 45 to 64 years, in
contrast, has been 14% and 19%, respectively.10 In Israel,
the mean age of patients requiring renal replacement ther-
apy grew from 56 years in 1990 to 66 years in 2010.
Whereas the number of new patients on dialysis rose by
66%, the number of new patients aged 75 years and older
rose by 191% in the same period and has been the largest
age group receiving renal replacement therapy since
2000. This trend has been accompanied by a constant
increase in the proportion of patients on hemodialysis
compared with peritoneal dialysis (73% hemodialysis
JOURNAL OF VASCULAR SURGERY
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dialysis in 2007).11 Not surprisingly, mortality rates in the
prevalent end-stage renal disease population aged 65 years
and older rise by age.10
Although central vein catheters are favored by some
authors for the elderly population,12 and more accesses
fail to mature in older patients,13 others have suggested
that age should not be a limiting factor for arteriovenous
access construction.14 It has also been shown that mortality
is higher in patients with central venous catheters for he-
modialysis than in those with arteriovenous ﬁstula or
graft.15,16 The 2006 update of the Kidney Disease Out-
comes Quality Initiative recommendations does not distin-
guish between younger and older patients.17 However, it
remains unclear whether constructing ﬁstulas in the elderly
will improve long-term patient survival or reduce
morbidity. There is evidence that increasing the rate of ﬁs-
tula construction may lead to a higher failure rate13 but also
that proper planning for surgery may counter this effect.18
In the present study using preoperative planning, 88% of
accesses constructed were autogenous, with 24-month sec-
ondary patency of 84% for radial-cephalic (forearm) ac-
cesses and 88% for brachial-cephalic (upper arm) accesses.
Elderly patients exhibit problems that may compromise
the success of dialysis access surgery, such as arterioscle-
rosis, poor-quality veins, thin skin, and comorbidities.19
One study of the factors associated with early failure of dial-
ysis access demonstrated a higher early failure rate in the
age group older than 80 years; the average time to ﬁrst fail-
ure was 230 days overall and 178 days in patients older
than 80 years.13 Other studies have not demonstrated an
association between age-related risk factors and surgical
success or patency.20-23 There is, therefore, no deﬁnite
conclusion that can be reached about the effect of age on
the rate of ﬁstula patency. Our study demonstrates that
advanced age is not a reason to avoid ﬁstula construction.
The average time to ﬁrst failure was 219 days for our pa-
tients older than 80 years. This improved result may be
due to our preoperative planning and aggressive approach
to monitoring and maintenance, all carried out by the
same access surgeon who performed the surgery.7,8
Whereas 1-year secondary patency in this study of elderly
patients was 91.7%, our overall 1-year secondary patency
in 220 patients of all ages with ﬁstulas in 2010 was 92%,
suggesting that there is no difference in patency rates be-
tween the elderly population compared with our dialysis ac-
cess surgery population.
The time to maturation for radial-cephalic ﬁstulas is
generally thought to be longer than for brachial-cephalic
ﬁstulas, and brachial-cephalic ﬁstulas are also believed to
have a higher surgical success rate and lower early failure
rate in patients aged 65 years and older.24,25 With this
and their limited life expectancy in mind, elderly candidates
for hemodialysis may be offered brachial-cephalic ﬁstulas to
minimize delays and to maximize dialysis time with that ﬁs-
tula. On the other hand, there is a higher incidence of steal
after proximal access procedures in older patients,26 and
additional studies have shown that age does not inﬂuenceﬁstula survival.27,28 In our patients, the difference in
primary patency and secondary patency between radial-
cephalic and brachial-cephalic ﬁstulas did not reach signiﬁ-
cance, and four patients required surgical revision for steal,
all upper arm ﬁstulas.
Eighteen polytetraﬂuoroethylene grafts were created in
elderly patients during the study period, only 12% of the
accesses created. In a systematic review of 34 studies by
Huber et al, both primary patency and secondary patency
were better for ﬁstula than for graft.29 In our study, the dif-
ference was not signiﬁcant, but the number of grafts was
small.
Primary patency has been shown to be decreased in dia-
betic patients, but secondary patency is the same as for non-
diabetics if ﬁstula complications are treated adequately.30
Others have shown that diabetes mellitus has no detrimental
effect on outcome after creation of autogenous elbow ﬁstulas
for hemodialysis.31 Our study did not demonstrate any dif-
ference in primary or secondary patency between diabetic pa-
tients and nondiabetics, indicating that there is no
justiﬁcation for regarding diabetes as a risk factor for ﬁstula
creation in octogenarians.
Maturation rates of more than 50% can be expected for
ﬁstula construction with an imaging protocol,17 but sur-
veillance and aggressive follow-up with early endovascular
intervention can yield high salvage rates in ﬁstulas that
fail to mature.32 A meta-analysis by Rooijens et al that
included eight prospective and 30 retrospective studies
found a primary failure rate of 15.3% for arteriovenous ﬁs-
tula (range, 6%-34%) with primary and secondary patency
of 63% and 66%, respectively.33 Subgroup analysis did
not reveal signiﬁcant differences for age. In the current
study, only seven of 128 patients (5.5%) with native ﬁstula
had early failure.
In hemodialysis patients 65 years and older, there is a
signiﬁcant increase in complication rate and mortality asso-
ciated with catheter use compared with both ﬁstula and
graft.34,35 Patients with permanent central venous catheters
for hemodialysis are treated by nephrologists who think
that there are medical conditions present precluding arte-
riovenous access construction. These patients are therefore
not referred to our center and were not included in the
study. The risk of death is up to 50% higher in patients us-
ing central venous catheters compared with those using
arteriovenous ﬁstulas or grafts.34,35 The mortality rate in
our patients aged 80 years and older with ﬁstula was
21.3% in the ﬁrst year, compared with a 1-year crude death
rate of 24.9% in the study of Medicare patients receiving
hemodialysis who were 67 years and older carried out by
Xue et al.35
This study has some limitations. This is a single-center
study, and although we are a large referral center, our re-
sults may not be generalizable to other centers. We do
not know how many elderly patients were not referred
and were dialyzed with central catheters; however, this
would also apply to younger patients who may be thought
unsuitable for access construction by the referring nephrol-
ogist. In addition, we do not have records of the patients
JOURNAL OF VASCULAR SURGERY
182 Olsha et al January 2015who were found to be unsuitable for access construction on
the basis of their inability to lie supine or unsuitability of
vessels for access construction. There was also a preponder-
ance of men in our study patients (66%) (Table I), which
could favor improved outcomes for access surgery.
CONCLUSIONS
Higher mortality rates in hemodialysis patients with
central vein catheters support the use of arteriovenous ac-
cess for elderly hemodialysis patients to reduce mortality
as well as to improve quality of life. Some authors have
recently advocated the use of grafts rather than ﬁstulas in
the age group older than 80 years.5,6,16,36 However, 88%
of patients in this study were found to have vasculature
that was suitable for autogenous access construction, with
patency and complication rates similar to those of their
younger counterparts when adequate preoperative plan-
ning and postoperative maintenance were carried out.
These patients should not be disqualiﬁed from access sur-
gery solely on account of their age. On the contrary, access
surgery should be encouraged as there may be no age limit
for this procedure. Our ﬁndings support the use of radial-
cephalic ﬁstula as the initial approach in elderly patients if
appropriate vessels are available and when adequate preop-
erative planning and postoperative maintenance are carried
out. This should result in fewer complications without
compromising patency while allowing maximal use of avail-
able vessels.
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